13F-HR filed by Lynx1 Capital Management LP
Lynx1 Capital Management LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 17 holding rows worth $275,939,282.
- Accession
- 0001892688-24-000091
- Filer
- CIK 1910456
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 17 entries on the cover page, a total value of $275,939,282 stated on the cover page (in dollars after the unit check, H1), rows summing to $275,939,282 with VALUE read as dollars as filed, 13F file number 028-22151. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerLynx1 Capital Advisors LLC 028-22145
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MERUS N V | N5749R100 | COM | 1,206,707 | $71,400,853 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 5,185,191 | $70,051,931 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,966,726 | $46,252,025 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 6,880,527 | $31,788,035 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 5,224,600 | $30,563,910 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 377,323 | $6,580,513 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,228,295 | $5,191,927 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 167,317 | $4,522,579 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 5,057,629 | $4,016,769 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 492,103 | $3,680,930 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 240,763 | $508,010 | dollars as filed | |
| BIONOMICS LIMITED | 09063M205 | ADS | 599,673 | $459,949 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795202 | COM | 43,499 | $426,756 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 9,500 | $177,365 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 17,400 | $157,122 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 3,800 | $128,706 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 16,194 | $31,902 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-24-000091 | this filing | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001892688-24-000100 | added | 2024-08-19 | acceptance time not in the bulk data set |